Current Ratio of Apellis Pharmaceuticals, Inc. from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Apellis Pharmaceuticals, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • Apellis Pharmaceuticals, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 387%, a 2.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Apellis Pharmaceuticals, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 387% -11% -2.7% 30 Sep 2025
Q2 2025 411% +15% +3.9% 30 Jun 2025
Q1 2025 443% +46% +12% 31 Mar 2025
Q4 2024 433% -24% -5.2% 31 Dec 2024
Q3 2024 397% -107% -21% 30 Sep 2024
Q2 2024 396% -174% -31% 30 Jun 2024
Q1 2024 397% -235% -37% 31 Mar 2024
Q4 2023 457% -220% -32% 31 Dec 2023
Q3 2023 504% -241% -32% 30 Sep 2023
Q2 2023 570% -134% -19% 30 Jun 2023
Q1 2023 632% +31% +5.1% 31 Mar 2023
Q4 2022 676% +93% +16% 31 Dec 2022
Q3 2022 746% +138% +23% 30 Sep 2022
Q2 2022 704% +10% +1.5% 30 Jun 2022
Q1 2022 601% -351% -37% 31 Mar 2022
Q4 2021 584% -436% -43% 31 Dec 2021
Q3 2021 608% -450% -43% 30 Sep 2021
Q2 2021 694% -379% -35% 30 Jun 2021
Q1 2021 952% +34% +3.7% 31 Mar 2021
Q4 2020 1020% +152% +18% 31 Dec 2020
Q3 2020 1058% -25% -2.3% 30 Sep 2020
Q2 2020 1073% -118% -9.9% 30 Jun 2020
Q1 2020 918% -681% -43% 31 Mar 2020
Q4 2019 868% -854% -50% 31 Dec 2019
Q3 2019 1082% -1037% -49% 30 Sep 2019
Q2 2019 1191% -841% -41% 30 Jun 2019
Q1 2019 1599% 31 Mar 2019
Q4 2018 1721% 31 Dec 2018
Q3 2018 2120% 30 Sep 2018
Q2 2018 2032% 30 Jun 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.